{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:08:04Z","timestamp":1760148484313,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The aim of this work was to study age, sex, and BMI (Body Mass Index)-related differences in the development of anti-SARS-CoV-2-Spike IgG antibodies, after vaccination with the BNT162b2 COVID-19 vaccine, in health care workers of a General Hospital in a city in Northern Greece. Blood sampling was drawn two to four weeks following the second dose of the vaccine, and six months after the first blood sample collection. Measurement of serum IgG antibodies against the spike domain of SARS-CoV-2 was performed using the SARS-CoV-2 IgG II Quant assay. All participants had sufficient serum IgG titers in the first measurement. Women developed higher IgG titers than men. The IgG titers were inversely related to age in both sexes; there was also a small, insignificant tendency to be inversely related to BMI. Six months after the first measurement, the IgG titers decreased dramatically to values less than 5% of the initial. This decrease was observed in both men and women and was inversely related to age. Multivariate regression analysis showed that age and sex explained with statistical significance 9% of the variance in SARS-CoV-2 IgG titers in our study population; the role of BMI was limited and insignificant.<\/jats:p>","DOI":"10.3390\/microorganisms11051279","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:31:36Z","timestamp":1684139496000},"page":"1279","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Age, Sex and BMI Relations with Anti-SARS-CoV-2-Spike IgG Antibodies after BNT162b2 COVID-19 Vaccine in Health Care Workers in Northern Greece"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-0288","authenticated-orcid":false,"given":"Paraskevi","family":"Papaioannidou","sequence":"first","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalypso","family":"Skoumpa","sequence":"additional","affiliation":[{"name":"Microbiological Department, General Hospital of Katerini, 601 00 Katerini, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Bostanitis","sequence":"additional","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Michailidou","sequence":"additional","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodouli","family":"Stergiopoulou","sequence":"additional","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Bostanitis","sequence":"additional","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tsalidou","sequence":"additional","affiliation":[{"name":"1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece"},{"name":"Microbiological Department, General Hospital of Katerini, 601 00 Katerini, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"82","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"2016","article-title":"Clinical characteristics of COVID-19 in New York City","volume":"29","author":"Faure","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E736","DOI":"10.1152\/ajpendo.00124.2020","article-title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus","volume":"318","author":"Muniyappa","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41430-020-0652-1","article-title":"Diabetes and COVID-19: Evidence, current status and unanswered research questions","volume":"74","author":"Gupta","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Norouzi, M., Norouzi, S., Ruggiero, A., Khan, M.S., Myers, S., Kavanagh, K., and Vemuri, R. (2021). Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061211"},{"key":"ref_6","first-page":"2019","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"2019","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijid.2020.03.031","article-title":"Transmission potential and severity of COVID-19 in South Korea","volume":"93","author":"Shim","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s42399-020-00341-w","article-title":"Coronavirus: Why Men are More Vulnerable to COVID-19 Than Women?","volume":"2","author":"Bwire","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0897.2011.01052.x","article-title":"Immunological differences in women compared with men: Overview and contributing factors","volume":"66","author":"Ghazeeri","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e0038821","DOI":"10.1128\/JCM.00388-21","article-title":"Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays in infected, recovered, and vaccinated groups","volume":"59","author":"Narishman","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1016\/j.vaccine.2021.08.025","article-title":"Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination","volume":"39","author":"Grupel","year":"2021","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/cid\/ciab219","article-title":"Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers","volume":"73","author":"Gruwier","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e0028821","DOI":"10.1128\/JCM.00288-21","article-title":"Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012\/V1 (United Kingdom) and VOC 202012\/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods","volume":"59","author":"English","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","unstructured":"(2023, April 21). Available online: https:\/\/covid19.gov.gr\/nomothesia-gia-ton-covid-19."},{"key":"ref_16","unstructured":"(2023, April 21). Available online: https:\/\/kavala.gov.gr\/kavala-simera\/anakoinwseis\/Deltia-Tipou\/2020\/eody-odigies-gia-xenodoxeio-se-karantina."},{"key":"ref_17","unstructured":"Giugliano, F. (2023, April 21). Greece Shows How to Handle the Crisis. Bloomberg (10 April 2020). Available online: https:\/\/www.bloomberg.com\/opinion\/articles\/2020-04-10\/greece-handled-coronavirus-crisis-better-than-italy-and-spain?leadSource=uverify%20wall."},{"key":"ref_18","first-page":"31","article-title":"Evaluation of Vaccination Effectiveness Against SARS-CoV-2 in Healthcare Professionals","volume":"2","author":"Tsalidou","year":"2021","journal-title":"EMJ Microbiol. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e09438","DOI":"10.1016\/j.heliyon.2022.e09438","article-title":"Antibody response after two doses of the BNT162b2 vaccine among healthcare workers of a Greek COVID 19 referral hospital: A prospective cohort study","volume":"8","author":"Tychala","year":"2022","journal-title":"Heliyon"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciab438","article-title":"The effectiveness of the two-dose BNT162b2 vaccine: Analysis of real-world data","volume":"74","author":"Chodick","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1515\/cclm-2021-0339","article-title":"Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA COVID-19 vaccination: A three-case series","volume":"59","author":"Danese","year":"2021","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"740708","DOI":"10.3389\/fimmu.2021.740708","article-title":"Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine","volume":"12","author":"Ciabattini","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Schiuma, G., Beltrami, S., Bortolotti, D., Rizzo, S., and Rizzo, R. (2022). Innate Immune Response in SARS-CoV-2 Infection. Microorganisms., 10.","DOI":"10.3390\/microorganisms10030501"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Visalli, G., Lagan\u00e0, A., Lo Giudice, D., Calimeri, S., Caccamo, D., Trainito, A., Di Pietro, A., and Facciol\u00e0, A. (2023). Towards a Future of Personalized Vaccinology: Study on Individual Variables Influencing the Antibody Response to the COVID-19 Vaccine. Vaccines, 11.","DOI":"10.3390\/vaccines11020217"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Anastassopoulou, C., Antoni, D., Manoussopoulos, Y., Stefanou, P., Argyropoulou, S., Vrioni, G., and Tsakris, A. (2022). Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0266958"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e057084","DOI":"10.1136\/bmjopen-2021-057084","article-title":"Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: A longitudinal observational cohort study in western Greece","volume":"12","author":"Parthymou","year":"2022","journal-title":"BMJ Open"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Renna, L.V., Bertani, F., Podio, A., Boveri, S., Carrara, M., Pinton, A., Milani, V., Spuria, G., Nizza, A.F., and Basilico, S. (2023). Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers. Vaccines, 11.","DOI":"10.3390\/vaccines11020463"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vassilaki, N., Gargalionis, A.N., Bletsa, A., Papamichalopoulos, N., Kontou, E., Gkika, M., Patas, K., Theodoridis, D., Manolis, I., and Ioannidis, A. (2021). Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers. Microorganisms, 9.","DOI":"10.3390\/microorganisms9081725"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Salvagno, G.L., Henry, B.M., di Piazza, G., Pighi, L., De Nitto, S., Bragantini, D., Gianfilippi, G.L., and Lippi, G. (2021). Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination. Diagnostics, 11.","DOI":"10.2139\/ssrn.3823718"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cangemi, R., Di Franco, M., Angeloni, A., Zicari, A., Cardinale, V., Visentini, M., Antonelli, G., Napoli, A., Anastasi, E., and Romiti, G.F. (2022). Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060994"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender Differences in Patients With COVID-19: Focus on Severity and Mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Israel, A., Shenhar, Y., Green, I., Merzon, E., Golan-Cohen, A., Sch\u00e4ffer, A.A., Ruppin, E., Vinker, S., and Magen, E. (2022). Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection. Vaccines, 10.","DOI":"10.1101\/2021.08.19.21262111"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1093\/cid\/ciab963","article-title":"Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination","volume":"75","author":"Canaday","year":"2022","journal-title":"Clin. Infect Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/5\/1279\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:34:20Z","timestamp":1760124860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/5\/1279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["microorganisms11051279"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11051279","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}